Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the subchronic gastrointestinal (GI) safety of PL3100 versus Naproxen in normal healthy volunteers.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01139190
Study type Interventional
Source PLx Pharma
Contact
Status Completed
Phase Phase 2
Start date July 2010
Completion date December 2010

See also
  Status Clinical Trial Phase
Completed NCT04586322 - Association Between Erosive Tooth Wear Progression and Dietary Risk Factors.